Investors

Atorvastatin. Funding Required: $3-5m for Phase IIb/III
Invention Title: Improvements in Tear Film Stability.
Multi-billion dollar market. Full patent coverage in Europe, Australia and Japan. In the process of amendments for the US.
As featured in Insight. Contact: kenneth.ooi@sydney.edu.au